.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Cipla
McKinsey
Chinese Patent Office
Medtronic
Deloitte
US Army
Harvard Business School
US Department of Justice

Generated: November 21, 2017

DrugPatentWatch Database Preview

Chamberlin Parenterl Company Profile

« Back to Dashboard

What is the competitive landscape for CHAMBERLIN PARENTERL, and what generic and branded alternatives to CHAMBERLIN PARENTERL drugs are available?

CHAMBERLIN PARENTERL has one approved drug.



Summary for Chamberlin Parenterl

US Patents:0
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chamberlin Parenterl
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION017130-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chamberlin Parenterl
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION017130-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chamberlin Parenterl
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION017130-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chamberlin Parenterl
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION017130-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
McKesson
Baxter
Cerilliant
Fuji
US Army
Fish and Richardson
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot